Safety, Tolerability, and Efficacy of Deferasirox in MDS
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
- Status
- UNKNOWN
- Phase
- NA
Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
- Status
- COMPLETED
- Phase
- NA
Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
- Status
- TERMINATED
- Phase
- PHASE2
Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase II Study of Maintenance With Azacitidine in MDS Patients
- Status
- TERMINATED
- Phase
- PHASE2
Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)
- Status
- UNKNOWN
- Phase
- PHASE2
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
- Status
- COMPLETED
- Phase
- PHASE2
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
- Status
- COMPLETED
- Phase
- PHASE3
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Lenalidomide in Subjects With intermediate2 or High MDS Associated With a Deletion (DEL) 5q [31]
- Status
- UNKNOWN
- Phase
- PHASE2
Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2